Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA.

Julie C LauffenburgerHelen TesfayeDaniel H SolomonElliott M AntmanRobert J GlynnSu Been LeeAngela TongNiteesh K Choudhry

Published in: BMJ open (2023)

Pill burden and pill size are key properties affecting adherence for almost all classes; others, like size and combination, could modestly affect medication adherence. Clinical interventions could screen patients for potential intolerance to medication and potentially implement more convenient dosing schedules.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
physical activity
risk factors
high throughput
type diabetes
metabolic syndrome
human health
adverse drug
drug induced